Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XGN - Exagen Inc


IEX Last Trade
2.96
-0.030   -1.014%

Share volume: 19,413
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$2.99
-0.03
-1.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-11-21 2022-11-21 2023-03-20 2023-05-15 2023-08-07 2023-11-13 2024-03-18 2024-05-13
Cash flow financing -264.000 K -22.000 K -173.000 K -62.000 K -10.242 M -108.000 K -220.000 K -100.000 K
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow -11.154 M -6.682 M -5.734 M -9.749 M -10.154 M -2.908 M 8.349 M -9.040 M
Net income -14.665 M -8.096 M -14.354 M -7.688 M -5.013 M -5.415 M -5.573 M -3.360 M
Depreciation 314.000 K 440.000 K 520.000 K 553.000 K 503.000 K 605.000 K 507.000 K 458.000 K
Changes in inventories 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Changes in receivables 8.715 M 10.639 M 6.077 M 9.303 M 16.235 M 17.044 M 6.551 M 10.901 M
Investing Cashflow -1.946 M -879.000 K -406.000 K -396.000 K -322.000 K -2.000 K -84.000 K -86.000 K
Net Borrowings -45.615 M -37.638 M -32.033 M -21.784 M -10.599 M -7.644 M -18.059 M -8.460 M
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures -1.946 M -879.000 K -406.000 K -396.000 K -324.000 K -2.000 K -106.000 K -86.000 K
Cash Change 76.387 M 68.704 M 62.391 M 52.184 M 31.466 M 28.448 M 36.493 M 27.267 M